38
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Performing Bronchoscopy in Times of the COVID-19 Pandemic: Practice Statement from an International Expert Panel

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          These recommendations for physicians who perform bronchoscopy will help to protect those patients (un)-affected by the current COVID-19 pandemic, minimize the risk of transmission, and maintain clinical care for all patients.

          Related collections

          Most cited references10

          • Record: found
          • Abstract: found
          • Article: not found

          Clinical Characteristics of Coronavirus Disease 2019 in China

          Abstract Background Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in Wuhan city and rapidly spread throughout China, data have been needed on the clinical characteristics of the affected patients. Methods We extracted data regarding 1099 patients with laboratory-confirmed Covid-19 from 552 hospitals in 30 provinces, autonomous regions, and municipalities in mainland China through January 29, 2020. The primary composite end point was admission to an intensive care unit (ICU), the use of mechanical ventilation, or death. Results The median age of the patients was 47 years; 41.9% of the patients were female. The primary composite end point occurred in 67 patients (6.1%), including 5.0% who were admitted to the ICU, 2.3% who underwent invasive mechanical ventilation, and 1.4% who died. Only 1.9% of the patients had a history of direct contact with wildlife. Among nonresidents of Wuhan, 72.3% had contact with residents of Wuhan, including 31.3% who had visited the city. The most common symptoms were fever (43.8% on admission and 88.7% during hospitalization) and cough (67.8%). Diarrhea was uncommon (3.8%). The median incubation period was 4 days (interquartile range, 2 to 7). On admission, ground-glass opacity was the most common radiologic finding on chest computed tomography (CT) (56.4%). No radiographic or CT abnormality was found in 157 of 877 patients (17.9%) with nonsevere disease and in 5 of 173 patients (2.9%) with severe disease. Lymphocytopenia was present in 83.2% of the patients on admission. Conclusions During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness. Patients often presented without fever, and many did not have abnormal radiologic findings. (Funded by the National Health Commission of China and others.)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

            In December 2019, novel coronavirus (2019-nCoV)-infected pneumonia (NCIP) occurred in Wuhan, China. The number of cases has increased rapidly but information on the clinical characteristics of affected patients is limited.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              Presumed Asymptomatic Carrier Transmission of COVID-19

              This study describes possible transmission of novel coronavirus disease 2019 (COVID-19) from an asymptomatic Wuhan resident to 5 family members in Anyang, a Chinese city in the neighboring province of Hubei.
                Bookmark

                Author and article information

                Journal
                Respiration
                Respiration
                RES
                Respiration
                S. Karger AG (Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH–4009, Basel, Switzerland · Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.com )
                0025-7931
                1423-0356
                28 April 2020
                : 1-6
                Affiliations
                [1] aDepartment of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China
                [2] bDepartment of Interventional Pneumology, Ruhrlandklinik, University Medicine Essen, Essen, Germany
                [3] cDepartment of Respiratory Medicine, Royal Brompton Hospital, London, United Kingdom
                [4] dNational Heart and Lung Institute, Imperial College, London, United Kingdom
                [5] eChelsea and Westminster Hospital, London, United Kingdom
                [6] fRespiratory Department, Santa Creu i Sant Pau Hospital, Barcelona, Spain
                [7] gDepartment Respiratory Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia
                [8] hDepartment Medicine, University of Melbourne, Parkville, Victoria, Australia
                [9] iDepartment of Biomedical Sciences and Public Health, Polytechnic University of Marche Region Azienda Ospedali Riuniti, Ancona, Italy
                [10] jDepartment of Respiratory and Critical Care Medicine, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China
                [11] kDivision of Pulmonary and Critical Care, Mayo Clinic Florida, Jacksonville, Florida, USA
                [12] lPneumology and Critical Care Medicine, Thoraxklinik University of Heidelberg, Heidelberg, Germany
                [13] mTranslational Lung Research Center Heidelberg, Heidelberg, Germany
                Author notes
                *Prof. Luo Fengming, Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041 (China), luofengming@ 123456hotmail.com
                Article
                res-0001
                10.1159/000507898
                7251585
                32344422
                d9a6a90c-a63f-431b-a7a2-ebb22ca81450
                Copyright © 2020 by S. Karger AG, Basel

                This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

                History
                : 14 April 2020
                : 14 April 2020
                Page count
                Figures: 3, Tables: 1, References: 17, Pages: 6
                Categories
                Interventional Pulmonology

                Respiratory medicine
                bronchoscopy,covid-19,interventional pneumology
                Respiratory medicine
                bronchoscopy, covid-19, interventional pneumology

                Comments

                Comment on this article